loadpatents
name:-0.0088949203491211
name:-0.010656833648682
name:-0.00050902366638184
Riedl; Jutta Patent Filings

Riedl; Jutta

Patent Applications and Registrations

Patent applications and USPTO patent grants for Riedl; Jutta.The latest application filed is for "topical compositions comprising ascomycins".

Company Profile
0.10.5
  • Riedl; Jutta - Grenzach N/A DE
  • Riedl, Jutta - Grenzach-Wyhlen DE
  • Riedl; Jutta - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Topical compositions comprising ascomycins
Grant 9,402,802 - Kriwet , et al. August 2, 2
2016-08-02
Topical Compositions Comprising Ascomycins
App 20120202841 - Kriwet; Katrin ;   et al.
2012-08-09
Topical compositions comprising ascomycins
App 20060058279 - Kriwet; Katrin ;   et al.
2006-03-16
Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
App 20050147629 - Riedl, Jutta ;   et al.
2005-07-07
Hormone replacement therapy method
Grant 6,551,611 - Elliesen , et al. April 22, 2
2003-04-22
Hormone replacement therapy method
App 20020142028 - Elliesen, Jorg ;   et al.
2002-10-03
Topical compositions comprising ascomycins
App 20010051650 - Kriwet, Katrin ;   et al.
2001-12-13
Hormone replacement therapy method and hormone dispenser
Grant 6,083,528 - Elliesen , et al. July 4, 2
2000-07-04
Hormone replacement therapy method and hormone dispenser
Grant 5,922,349 - Elliesen , et al. July 13, 1
1999-07-13
Hormone replacement therapy method and hormone dispenser
Grant 5,897,539 - Elliesen , et al. April 27, 1
1999-04-27
Agent for transdermal administration that contains gestodene esters
Grant 5,858,394 - Lipp , et al. January 12, 1
1999-01-12
Gestodene-containing agent for transdermal administration
Grant 5,788,984 - Guenther , et al. August 4, 1
1998-08-04
Transdermal therapeutic systems with crystallization inhibitors
Grant 5,676,968 - Lipp , et al. October 14, 1
1997-10-14
Agent for transdermal administration containing ergoline derivatives
Grant 5,399,355 - Riedl , et al. March 21, 1
1995-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed